Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 27,587Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Future Health Pharma Gmbh

02 23LXO Group

03 2LXO IRELAND

04 20Novartis Pharmaceuticals Corporation

05 2PH HEALTH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Brand Name : TEKTURNA HCT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-18

Application Number : 22107

Regulatory Info : DISCN

Registration Country : USA

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Brand Name : TEKTURNA HCT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-18

Application Number : 22107

Regulatory Info : DISCN

Registration Country : USA

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Brand Name : TEKTURNA HCT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-18

Application Number : 22107

Regulatory Info : DISCN

Registration Country : USA

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Brand Name : TEKTURNA HCT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-18

Application Number : 22107

Regulatory Info : DISCN

Registration Country : USA

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : TEKTURNA

Dosage Form : CAPSULE, PELLET;ORAL

Dosage Strength : EQ 37.5MG BASE

Packaging :

Approval Date : 2017-11-14

Application Number : 210709

Regulatory Info : DISCN

Registration Country : USA

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; VALSARTAN

Brand Name : VALTURNA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;160MG

Packaging :

Approval Date : 2009-09-16

Application Number : 22217

Regulatory Info : DISCN

Registration Country : USA

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; VALSARTAN

Brand Name : VALTURNA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;320MG

Packaging :

Approval Date : 2009-09-16

Application Number : 22217

Regulatory Info : DISCN

Registration Country : USA

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Brand Name : TEKAMLO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;EQ 5MG BASE

Packaging :

Approval Date : 2010-08-26

Application Number : 22545

Regulatory Info : DISCN

Registration Country : USA

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Brand Name : TEKAMLO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;EQ 10MG BASE

Packaging :

Approval Date : 2010-08-26

Application Number : 22545

Regulatory Info : DISCN

Registration Country : USA

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Brand Name : TEKAMLO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 5MG BASE

Packaging :

Approval Date : 2010-08-26

Application Number : 22545

Regulatory Info : DISCN

Registration Country : USA

blank

11

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Brand Name : TEKAMLO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 10MG BASE

Packaging :

Approval Date : 2010-08-26

Application Number : 22545

Regulatory Info : DISCN

Registration Country : USA

blank

12

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;EQ 5MG BASE;12.5MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

13

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 5MG BASE;12.5MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

14

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 5MG BASE;25MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

15

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 10MG BASE;12.5MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

16

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 10MG BASE;25MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

17

LXO IRELAND

Country
Health 2.0 Conference
Not Confirmed
arrow

LXO IRELAND

Country
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : TEKTURNA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2007-03-05

Application Number : 21985

Regulatory Info : RX

Registration Country : USA

blank

18

LXO IRELAND

Country
Health 2.0 Conference
Not Confirmed
arrow

LXO IRELAND

Country
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : TEKTURNA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE

Packaging :

Approval Date : 2007-03-05

Application Number : 21985

Regulatory Info : RX

Registration Country : USA

blank

19

PH HEALTH

Country
Health 2.0 Conference
Not Confirmed
arrow

PH HEALTH

Country
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : ALISKIREN HEMIFUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2019-03-22

Application Number : 206665

Regulatory Info : RX

Registration Country : USA

blank

20

PH HEALTH

Country
Health 2.0 Conference
Not Confirmed
arrow

PH HEALTH

Country
arrow
Health 2.0 Conference
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : ALISKIREN HEMIFUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE

Packaging :

Approval Date : 2019-03-22

Application Number : 206665

Regulatory Info : RX

Registration Country : USA

blank